Actym Therapeutics Funding & Investors
Actym Therapeutics, based in Berkeley, CA, is a privately-held biotechnology company focused on discovery and development of novel immuno-oncology therapies to treat cancer. The company has developed an attenuated, microbial-based, immunotherapeutic technology platform called STACT (S. Typhimurium-A... Read more
actymthera.comTotal Amount Raised: $59,500,000
Actym Therapeutics Funding Rounds
Series A
$25,500,000
Series A Investors
Boehringer Ingelheim Venture FundIllumina VenturesGKCCJLo VenturesPanacea VentureSeries A
$34,000,000
Series A Investors
Boehringer Ingelheim Venture FundPanacea VentureJLo VenturesIllumina VenturesKorea Investment Partners
Funding info provided by Diffbot.